Ownership Submission
FORM 3
 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Expires: January 31, 2005
Estimated average burden hours per response... 0.5

(Print or Type Responses)
1. Name and Address of Reporting Person *
  Frank Kenneth
 2. Date of Event Requiring Statement (Month/Day/Year)
09/24/2013		 3. Issuer Name and Ticker or Trading Symbol
PALL CORP [PLL]
(Last)
(First)
(Middle)
C/O PALL CORPORATION, 25 HARBOR PARK DRIVE		 4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director _____ 10% Owner
__X__ Officer (give title below) _____ Other (specify below)
SVP, Pres. BioPharmaceuticals
 5. If Amendment, Date Original Filed(Month/Day/Year)
(Street)

PORT WASHINGTON, NY 11050		 6. Individual or Joint/Group Filing(Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
(City)
(State)
(Zip)
Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4)		 2. Amount of Securities Beneficially Owned
(Instr. 4)		 3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)		 4. Nature of Indirect Beneficial Ownership
(Instr. 5)
Common Stock 1,514
D
 

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. SEC 1473 (7-02)
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 4)		 2. Date Exercisable and Expiration Date
(Month/Day/Year)		 3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)		 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)		 6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Employee Stock Options (Rights to Buy) 07/14/2014 07/14/2017 Common Stock 963 $ 36.64 D  
Employee Stock Options (Rights to Buy) 07/13/2012 07/13/2018 Common Stock 652 $ 55.67 D  
Employee Stock Options (Rights to Buy) 07/13/2013 07/13/2018 Common Stock 653 $ 55.67 D  
Employee Stock Options (Rights to Buy) 07/13/2014 07/13/2018 Common Stock 652 $ 55.67 D  
Employee Stock Options (Rights to Buy) 07/13/2015 07/13/2018 Common Stock 653 $ 55.67 D  
Employee Stock Options (Rights to Buy) 01/18/2013 01/18/2019 Common Stock 612 $ 59.75 D  
Employee Stock Options (Rights to Buy) 01/18/2014 01/18/2019 Common Stock 613 $ 59.75 D  
Employee Stock Options (Rights to Buy) 01/18/2015 01/18/2019 Common Stock 612 $ 59.75 D  
Employee Stock Options (Rights to Buy) 01/18/2016 01/18/2019 Common Stock 613 $ 59.75 D  
Employee Stock Options (Rights to Buy) 01/16/2014 01/16/2020 Common Stock 2,037 $ 64.8 D  
Employee Stock Options (Rights to Buy) 01/16/2015 01/16/2020 Common Stock 2,038 $ 64.8 D  
Employee Stock Options (Rights to Buy) 01/16/2016 01/16/2020 Common Stock 2,037 $ 64.8 D  
Employee Stock Options (Rights to Buy) 01/16/2017 01/16/2020 Common Stock 2,038 $ 64.8 D  
Restricted Stock Units 07/14/2014 07/14/2014 Common Stock 2,306.7 $ (1) D  
Restricted Stock Units 07/13/2015 07/13/2015 Common Stock 1,559.98 $ (1) D  
Restricted Stock Units 01/18/2016 01/18/2016 Common Stock 1,456.32 $ (1) D  
Restricted Stock Units 01/16/2017 01/16/2017 Common Stock 2,355 $ (1) D  
Bonus Units 09/25/2013 09/25/2013 Common Stock 3,554.95 $ (2) D  
After Tax Units 10/06/2014 10/06/2014 Common Stock 4,948.11 $ (2) D  
After Tax Units 02/08/2015 02/08/2015 Common Stock 7,573.96 $ (2) D  
Bonus Units 10/05/2016 10/05/2016 Common Stock 9,508.75 $ (2) D  
After Tax Units 10/13/2016 10/13/2016 Common Stock 4,760.42 $ (2) D  

Reporting Owners

Reporting Owner Name / Address Relationships
Director 10% Owner Officer Other
Frank Kenneth
C/O PALL CORPORATION
25 HARBOR PARK DRIVE
PORT WASHINGTON, NY 11050		       SVP, Pres. BioPharmaceuticals  

Signatures

/s/ Cherita Thomas as Attorney-in-Fact for Kenneth Frank 09/30/2013
**Signature of Reporting Person Date

Explanation of Responses:

* If the form is filed by more than one reporting person, see Instruction 5(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1) The Units will vest and become convertible into shares of Common Stock of the Issuer on a one-for-one basis on the date shown in column 2, provided the Reporting Person is still employed by the Issuer or a subsidiary on that date. If employment terminates sooner, the Units will be forfeited unless termination of employment occurs because of death, disability or retirement, in any of which events the Units may vest in whole or in part.
(2) The Units will vest and become convertible into shares of Common Stock of the Issuer on a one-for-one basis on the date shown in column 2, subject to adjustments if the Reporting Person's employment with the Issuer terminates under certain circumstances prior to the fourth anniversary of the date on which the Units were granted, or, if later, the date to which the Reporting Person elects to defer receipt of common stock beyond the vesting date.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, See Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.